Stockreport

Natera Presents Updated Analyses From ALTAIR Clinical Trial at ASCO GI

Natera, Inc.  (NTRA) 
Last natera, inc. earnings: 2/26 04:10 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.natera.com
PDF Study showed a statistically significant disease-free survival (DFS) benefit in all SignateraTM-positive patients following blinded central review AUSTIN, Texas--(BUS [Read more]